The latest prices for a box of different versions of Ukeron are announced

Urocalun is a urinary tract stone treatment agent originating from Japan. Its main ingredient is oak extract powder. It is widely used to promote the excretion of kidney stones and ureteral stones. This article will conduct a detailed analysis of the latest prices, domestic listings and efficacy of different versions of Ukeron to help readers fully understand this drug.

The latest prices for a box of different versions of Ukeron are announced

As an imported drug, its price varies depending on the version and sales channel. Understanding its latest price information can help patients make more reasonable drug purchasing choices.

The price of Japan’s original version of Ukeron

The original Japanese version of Ukeron is produced by Nippon Shinyaku Co., Ltd. and currently sells for about US$57 per box in the Chinese market. This price is relatively high mainly due to import costs and brand premium.

Price comparison of versions in other regions

In addition to the Japanese original version, Ukeron is also sold in other international markets, but prices may vary due to tariffs and logistics costs. For example, the selling price in some Asian countries may be slightly lower than the market price in China.

Price is an important reference factor for patients when choosing drugs. As an imported drug, Ukeron has a relatively high price, but its efficacy and safety have been widely recognized.

Ukeron’s domestic launch situation

Ukeron has been launched in China, but its medical insurance coverage and the status of generic drugs still require further attention.

Time to market and market performance

After Ukeron was launched in China, it quickly gained the attention of doctors and patients. Its natural plant ingredients and clear efficacy make it one of the commonly used drugs for the treatment of urinary tract stones.

Current status of medical insurance coverage and generic drugs

Currently, Ukeron has not been included in China’s medical insurance, and patients need to purchase it at their own expense. In addition, there are no generic drugs of Ukeron on the market, and the original drug is still the only option.

The launch of Ukeron in China provides a new treatment option for patients with urinary tract stones, but its lack of medical insurance coverage and generic drugs may limit its use by some patients.

Efficacy of Euclone

The main indication of Euclid is to promote the excretion of kidney stones and ureteral stones, and its efficacy has been verified in clinical practice.

Mechanism of Action and Indications

The main component of Ukeron is Quercus vinifera extract powder. Its mechanism of action is not yet completely clear, but clinical data shows that it can effectively promote the excretion of stones and is suitable for patients diagnosed with kidney stones or ureteral stones through imaging examinations.

Clinical effects and patient feedback

According to clinical trials and patient feedback, Ukeron has a significant effect on stone discharge, with a low incidence of side effects, mostly mild digestive system discomfort.

The efficacy and safety of Uclone make it an important choice for the treatment of urinary tract stones, but its specific mechanism of action still requires further study.